HOTH THERAPEUTICS, INC. UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Laidlaw & Company (UK) Ltd. is acting as the representative (the “Representative”), an aggregate of [●] authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional [●] shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares.” The Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) are collectively referred to as the “Securities.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 30, 2017, between Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of this 1st day of June 2017 (the “Effective Date”), by and between Hoth Theraputics, a Nevada corporation with offices at One Rockefeller Plaza, New York, New York, 10020 (the “Corporation”), and Robb Knie, an individual residing at 6 Horizon Road, Fort Lee, New Jersey 07024 (the “Executive”), under the following circumstances:
INVESTOR RIGHTS AGREEMENT BY AND BETWEEN HOTH THERAPEUTICS INC. AND THE INVESTORS PARTY HERETO August , 2017 INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS INVESTOR RIGHTS AGREEMENT (the“ Agreement”) is entered into as of August , 2017, by between Hoth Therapeutics Inc., a Nevada corporation (the “Company”) and the persons identified on Exhibit A hereto (collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 30, 2017, between Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”) to the Employment Agreement dated as of August 4, 2017 is entered into between by and between Hoth Therapeutics, a Nevada corporation (the “Company”) and Robb Knie (the “Executive”).
AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • December 14th, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
WHEREAS, the Company and the Existing Stockholders are parties to that certain Stockholders Agreement dated as of June 30, 2017;
